Tonix Pharmaceuticals Receives FDA Guidance To Continue Development of Therapy For Fibromyalgia
News
The Tonix Pharmaceuticals Holding Corp. received written guidance from the United States Food and Drug Administration (FDA) on the company’s Phase 3 clinical trials for the TNX-102 SL in fibromyalgia. Seth Lederman, ... Read more